U.S. markets close in 44 minutes
  • S&P 500

    3,818.37
    +32.99 (+0.87%)
     
  • Dow 30

    31,060.96
    +285.53 (+0.93%)
     
  • Nasdaq

    11,099.09
    +70.36 (+0.64%)
     
  • Russell 2000

    1,721.57
    +13.58 (+0.79%)
     
  • Crude Oil

    108.31
    +2.55 (+2.41%)
     
  • Gold

    1,808.60
    +1.30 (+0.07%)
     
  • Silver

    19.80
    -0.55 (-2.71%)
     
  • EUR/USD

    1.0433
    -0.0050 (-0.48%)
     
  • 10-Yr Bond

    2.8890
    -0.0830 (-2.79%)
     
  • GBP/USD

    1.2099
    -0.0076 (-0.63%)
     
  • USD/JPY

    135.2200
    -0.5080 (-0.37%)
     
  • BTC-USD

    19,413.40
    +462.30 (+2.44%)
     
  • CMC Crypto 200

    418.67
    -1.47 (-0.35%)
     
  • FTSE 100

    7,168.65
    -0.63 (-0.01%)
     
  • Nikkei 225

    25,935.62
    -457.42 (-1.73%)
     

InMode to Participate at the UBS Healthcare One-on-One Virtual Day

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

YOKNEAM, Israel, May 23, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer, will participate at the UBS Healthcare One-on-One Virtual Day on June 1st, 2022. To schedule a meeting, please contact your UBS representative or Miri Segal at msegal@ms-ir.com.

InMode Logo
InMode Logo

For more information about the event, visit InMode's investor relations site here.

About InMode 

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

Investor Relations Contact:

Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com 
917-607-8654

Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

Cision
Cision

View original content:https://www.prnewswire.com/news-releases/inmode-to-participate-at-the-ubs-healthcare-one-on-one-virtual-day-301552186.html

SOURCE InMode Ltd.